PharmaJet and Vaccibody inked a collaborative deal to provide needle-free injection tech for the development of a human papillomavirus vaccine.
HPV is the cause of virtually all cervical cancer, according to the National Cancer Institute, and just 2 types of HPV, 16 and 18, are responsible for about 70% of all cases.
Get the full story at our sister site, Drug Delivery Business News.
The post PharmaJet, Vaccibody collaborate on needle-free HPV vaccine appeared first on MassDevice.
from MassDevice http://ift.tt/2eDhjDJ
Cap comentari:
Publica un comentari a l'entrada